Drug Safety

Gold Standards in Pharmacovigilance: The Use of Definitive Anecdotal Reports of Adverse Drug Reactions as Pure Gold and High-Grade Ore
pp. 645-655(11)
Authors: Hauben, Manfred; Aronson, Jeffrey K.

Safety Profile of Meropenem: An Updated Review of Over 6000 Patients Treated with Meropenem
pp. 657-668(12)
Author: Linden, Peter

Physician Response to Patient Reports of Adverse Drug Effects: Implications For Patient-Targeted Adverse Effect Surveillance
pp. 669-675(7)
Authors: Golomb, Beatrice A.; McGraw, John J.; Evans, Marcella A.; Dimsdale, Joel E.

Allergic Reactions to Medicines Derived from Pelargonium Species
pp. 677-680(4)
Authors: de Boer, Hugo J.; Hagemann, Ulrich; Bate, Jenny; Meyboom, Ronald H.B.

A Modified Prescription-Event Monitoring Study to Assess the Introduction of Seretide Evohaler™ in England: An Example of Studying Risk Monitoring in Pharmacovigilance
pp. 681-695(15)
Authors: Perrio, Michael J.; Wilton, Lynda V.; Shakir, Saad A.W.

Telithromycin Use and Spontaneous Reports of Hepatotoxicity
pp. 697-703(7)
Authors: Dore, David D.; DiBello, Julia R.; Lapane, Kate L.

Incidence of Allergic Reactions Associated with Antibacterial Use in a Large, Managed Care Organisation
pp. 705-713(9)
Authors: Johannes, Catherine B.; Ziyadeh, Najat; Seeger, John D.; Tucker, Ed; Reiter, Christoph; Faich, Gerald

Criteria Revision and Performance Comparison of Three Methods of Signal Detection Applied to the Spontaneous Reporting Database of a Pharmaceutical Manufacturer
pp. 715-726(12)
Authors: Matsushita, Yasuyuki; Kuroda, Yasufumi; Niwa, Shinpei; Sonehara, Satoshi; Hamada, Chikuma; Yoshimura, Isao

Drug-Induced Endocrine and Metabolic Disorders
pp. 727-728(2)
Authors: Chaker Ben Salem,; Slim, Raoudha; Elouni, Bouraoui; Hmouda, Houssem; Bouraoui, Kamel

The Authors' Reply
pp. 728-729(2)
Authors: C.W., Ronald; Kong, Alice P.S.; Chan, Norman N.; Tong, Peter C.Y.; Chan, Juliana C.N.